Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06403436
Title A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors (TT-CSP-001)
Acronym TT-CSP-001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TOLREMO therapeutics AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | CHE


No variant requirements are available.